BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29401560)

  • 1. Budget Impact of the Accreditation Program for Clinical Laboratories on Colorectal Cancer Screening via Fecal Immunochemical Testing: Results from the National Cancer Screening Program in Korea.
    Jun JK; Sung NY; Song SH; Hong S; Jang MA; Song J; Kim JH; Min WK; Lee YK
    Ann Lab Med; 2018 May; 38(3):249-254. PubMed ID: 29401560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the National Cancer Screening Program for colorectal cancer in the Republic of Korea, 2004-2009.
    Park MJ; Choi KS; Jun JK; Lee HY
    Asian Pac J Cancer Prev; 2011; 12(12):3489-93. PubMed ID: 22471503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Accreditation on Accuracy of Diagnostic Tests in Medical Laboratories.
    Jang MA; Yoon YA; Song J; Kim JH; Min WK; Lee JS; Lee YW; Lee YK
    Ann Lab Med; 2017 May; 37(3):213-222. PubMed ID: 28224767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
    Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
    Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program.
    Park MJ; Choi KS; Lee YK; Jun JK; Lee HY
    Scand J Gastroenterol; 2012 Apr; 47(4):461-6. PubMed ID: 22428929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.
    Toes-Zoutendijk E; van Leerdam ME; Dekker E; van Hees F; Penning C; Nagtegaal I; van der Meulen MP; van Vuuren AJ; Kuipers EJ; Bonfrer JMG; Biermann K; Thomeer MGJ; van Veldhuizen H; Kroep S; van Ballegooijen M; Meijer GA; de Koning HJ; Spaander MCW; Lansdorp-Vogelaar I;
    Gastroenterology; 2017 Mar; 152(4):767-775.e2. PubMed ID: 27890769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance for faecal occult blood testing: quantitative immunochemical method (FIT-HB) in colorectal cancer screening programmes.
    Rubeca T; Rapi S; Deandrea S; Malaspina M; Passamonti BU; Grassi E; Cioccarelli AM; Marchetti E; Boni M; Cellai F; Pradella M; Gattafoni F; Rotolo S
    Epidemiol Prev; 2017; 41(5-6 (Suppl 1)):1-31. PubMed ID: 29129048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the FIT-based National Colorectal Cancer Screening Program in Slovenia.
    Tepeš B; Bracko M; Novak Mlakar D; Stefanovic M; Stabuc B; Frkovic Grazio S; Maucec Zakotnik J
    J Clin Gastroenterol; 2017 Jul; 51(6):e52-e59. PubMed ID: 27552327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accreditation of mammography facilities by the American College of Radiology: results of a national survey.
    Brown ML; Fintor L
    Am J Prev Med; 1994; 10(3):162-7. PubMed ID: 7917443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study.
    Lew JB; St John DJB; Xu XM; Greuter MJE; Caruana M; Cenin DR; He E; Saville M; Grogan P; Coupé VMH; Canfell K
    Lancet Public Health; 2017 Jul; 2(7):e331-e340. PubMed ID: 29253458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.
    Ibáñez-Sanz G; Garcia M; Rodríguez-Moranta F; Binefa G; Gómez-Matas J; Domènech X; Vidal C; Soriano A; Moreno V;
    Dig Liver Dis; 2016 Oct; 48(10):1249-54. PubMed ID: 27378703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Kim NH; Park JH; Park DI; Sohn CI; Choi K; Jung YS
    Yonsei Med J; 2017 Jan; 58(1):150-157. PubMed ID: 27873508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of the National Cancer Screening Program for Colorectal Cancer in Korea over 14 Years (2004-2017).
    Park B; Her EY; Lee K; Nari F; Jun JK; Choi KS; Suh M
    Cancer Res Treat; 2023 Jul; 55(3):910-917. PubMed ID: 36915246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implementation and effects of a clinical laboratory accreditation program in Korea from 1999 to 2006.
    Shin BM; Chae SL; Min WK; Lee WG; Lim YA; Lee DH; Lim HS; Lee YK; Cha YJ; Suh SP; Lee KN; Kwak YS
    Korean J Lab Med; 2009 Apr; 29(2):163-70. PubMed ID: 19411785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Has the National Cancer Screening Program reduced income inequalities in screening attendance in South Korea?
    Kim S; Kwon S; Subramanian SV
    Cancer Causes Control; 2015 Nov; 26(11):1617-25. PubMed ID: 26335263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.
    Kapidzic A; van der Meulen MP; Hol L; van Roon AH; Looman CW; Lansdorp-Vogelaar I; van Ballegooijen M; van Vuuren AJ; Reijerink JC; van Leerdam ME; Kuipers EJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1464-71.e4. PubMed ID: 25724706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.